Cart
sales@molnova.com
SRI-37330
CAS No. 2322245-42-9
SRI-37330( —— )
Catalog No. M28482 CAS No. 2322245-42-9
SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 600 | In Stock |
|
| 100MG | 889 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSRI-37330
-
NoteResearch use only, not for human use.
-
Brief DescriptionSRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
-
DescriptionSRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
-
In VitroSRI-37330 (1 μM, 24 h) inhibits the activity of the human TXNIP promoter in INS-1 cells.SRI-37330 (1 μM, 24 h) inhibits Mrna and protein levels of TXNIP in INS-1 cells.SRI-37330 (5 μM, 24 h) inhibits polymerase II (Pol II) binding to the E-box motif region of the TXNIP promoter.SRI-37330 (5 μM, 24 h) lowers glucagon secretion in TC1-6 cells.SRI-37330 (0-5 μM, 24 h) inhibits glucagon-induced glucose output from primary hepatocytes.RT-PCR Cell Line:INS-1 cells Concentration:1 μM Incubation Time:24 h Result:Inhibited endogenous TXNIP mRNA expression with an IC50 of 0.64 μM.
-
In VivoSRI-37330 (100 mg/kg, p.o., in drinking water, 3 weeks) decreases glucagon secretion and action and blocks hepatic glucose output.SRI-37330 (100 mg/kg, p.o., in drinking water, 3 weeks) is well tolerated in male C57BL/6J mice.SRI-37330 (100 mg/kg, p.o., in drinking water, 3 weeks) reverses obesity- and STZ-induced diabetes and hepatic steatosis in mice. Animal Model:C57BL/6J mice Dosage:100 mg/kg Administration:Oral administration (p.o.), in drinking water, 3 weeks.Result:Lowered serum glucagon levels, inhibited hepatic glucose production and improved glucose homeostasis in mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2322245-42-9
-
Formula Weight388.41
-
Molecular FormulaC16H19F3N4O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (257.46 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Phenyl-ac-Gly-OH
Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. The presence of phenylacetylglycine in urine has been confirmed for dogs rats and mice. However the presence of this compound in human urine is controversial. GC-MS studies have not found this compound while NMR studies claimed to have identified it.
-
β-lonone
β-lonone is an end-ring analog of β-carotenoids which widely distributed in fruit and vegetableswith?anti-proliferative anti-metastatic.
-
lsocryptomerin
lsocryptomerin is a membrane-active antifungal compound that can be isolated from Selaginella tamariscina. lsocryptomerin can depolarize fungal plasma membrane. lsocryptomerin also shows anticancer and antibacterial activities.
